Product Information
ENOXAPARIN 40 MG/0.4 ML SYR is a generic product labeled by Fresenius Kabi USA, LLC, priced at $7.7791 per ML under NDC 63323053587. Its NADAC has been published 328 times since Jun 24, 2020.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
Strength
40 mg/.4mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323053587
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has been published 328 times since Jun 24, 2020, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.7791 per ML |
|---|---|
| All-time high | $14.6704 (Nov 10, 2021) |
| All-time low | $7.7791 (Sep 23, 2026) |
| 52-week high | $9.2335 |
| 52-week low | $7.7791 |
| Median price | $11.3131 |
| Average price | $11.1037 |
| Largest weekly change | +23.8% (Nov 22, 2023) |
| Weeks tracked | 328 |
| Tracking since | Jun 24, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
enoxaparin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 40 MG/0.4 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 40 MG/0.4 ML SYR, manufactured by Fresenius Kabi USA, LLC, is $7.7791 per ML (NDC 63323053587), effective Sep 30, 2026.
How has the price of ENOXAPARIN 40 MG/0.4 ML SYR changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has declined 33.1%. It has been tracked across 328 weekly CMS publications since Jun 24, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 40 MG/0.4 ML SYR?
Since Jun 24, 2020, the NADAC for ENOXAPARIN 40 MG/0.4 ML SYR has ranged from a low of $7.7791 (Sep 23, 2026) to a high of $14.6704 (Nov 10, 2021), with a median of $11.3131 per ML.
Are there cheaper alternatives to ENOXAPARIN 40 MG/0.4 ML SYR?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOVENOX 40 MG/0.4 ML SYRINGE, is $6.7750 per ML — about 13% below ENOXAPARIN 40 MG/0.4 ML SYR.
Who manufactures ENOXAPARIN 40 MG/0.4 ML SYR?
ENOXAPARIN 40 MG/0.4 ML SYR (NDC 63323053587) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.